What Would A Short Seller Say About Astera Labs? Trefis Team Fri, November 13, 2026 at 6:40 PM EST 4 min read ALAB -4.84% ^GSPC -0.40% SPGI +1.08% Explore stocks on Coinbase Trading disclosure Trading disclosure The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.
For questions about this article or underlying research, email help@trefis.com.
If you own Astera Labs (ALAB), the past month hurt: the stock lost 24.1% in the month to November 12, 2026, while the S&P 500 slipped 1.6%. A short seller, someone betting the stock keeps falling, would find little to attack in the latest quarter's sales and more in a faster-growing peer and in how long growth this fast can last.
Management's story is upbeat. On its November 3 call, it said the workload mix is shifting to inference, "where continuous reasoning loops multiply the traffic crossing the fabric" that links AI chips. For a holder, that is a comforting story. So where would a skeptic push back?
Where A Short Seller Would Push On Astera Labs
A short seller would start with two questions, comparing each company over its own latest four fiscal quarters as reported.
If AI demand is this strong, why does a peer grow faster? Credo Technology's revenue rose 165.1%, compared with 115.2% for Astera Labs. Credo also kept 31.7 cents of operating profit from each dollar of sales, against 25.5 cents at Astera Labs, while Broadcom and Rambus kept even more.
And if demand is still building, why has its twelve-month growth slowed? A year earlier, Astera Labs' twelve-month revenue growth was 136.5%, faster than today's pace, though growth in each single quarter has picked up since. Even so, at today's pace, Astera Labs grew faster than every peer except Credo.
What Astera Labs' Management Said Plainly
Management was candid on the same call. It said the initial Scorpio X platforms, the switches that led the latest quarter's growth, have completed much of their first deployment ramps. It expects further growth from new platforms and additional customers through 2027.
On optics, management said its focus is on scale-up, a market it called small today. It expects that market to reach $40 billion by 2030. It also said operating costs, on the adjusted basis used on the call, should run at around 30% of revenue over the longer term. On that basis, they are below that level today because revenue has grown so fast; on the reported figures used elsewhere in this article, they run nearer 42%. On the adjusted basis, that implies costs taking a larger share of each dollar of sales over time.
Astera Labs' Gross Margin Is Narrowing
For an owner, the strain shows in gross margin, the share of sales left after the cost of making the chips. Gross margin was 72.3% in fiscal Q3 2026, down from 76.2% in fiscal Q3 2025, and it fell in each of the last two quarters.
Costs are climbing too. Management said its headcount has doubled from a year earlier. Operating margin still widened, reaching 30.6% in fiscal Q3 2026 from 24.0% a year earlier, so the pressure is on chip costs, not overall profit.
Why Owners Might Hold On To Astera Labs
The sales multiple has already come down a long way, as sales more than doubled. Astera Labs trades at 25.5 times its sales over the last four quarters, against 45.3 times at the end of September 2025, though that is still far above the S&P 500's 3.2 times.
The business is also speeding up quarter by quarter. Revenue growth from a year earlier rose in each of the last three quarters, reaching 153.7% in fiscal Q3 2026, when Scorpio became the company's largest product family. For the fourth quarter, management expects revenue of $730 million to $750 million. That compares with $584.9 million in fiscal Q3 2026.
So does management's demand story answer the skeptic? Partly: the latest quarters back it up, while the narrowing gross margin and the largely completed first Scorpio X ramps give skeptics something real to point to. Astera Labs' revenue growth in its fiscal Q4 2026 report, expected in February 2027, is the number to watch.
Want Income That Doesn't Hang On One Company?
Every single stock carries risks like these. The Trefis Income Solution spreads your money across 50 dividend stocks, each with at least 10 straight years of dividends, with a yield about 3x the S&P 500.
Spot an error or want more like this? Tell us in 10 seconds.
